Julian Norman Kenyon is Chief Scientific Officer of Propanc Biopharma, Inc.. Currently has a direct ownership of 3.42 Million shares of PPCB, which is worth approximately $0. The most recent transaction as insider was on Aug 17, 2021, when has been sold 3,420,000 shares (Common Stock, par value $0.001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.42M
0% 3M change
0% 12M change
Total Value Held $0

Julian Norman Kenyon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 17 2021
BUY
Grant, award, or other acquisition
-
3,420,000 Added 50.0%
3,420,005 Common Stock, par valu...
JNK

Julian Norman Kenyon

Chief Scientific Officer
Camberwell, Vic,, C3

Track Institutional and Insider Activities on PPCB

Follow Propanc Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PPCB shares.

Notify only if

Insider Trading

Get notified when an Propanc Biopharma, Inc. insider buys or sells PPCB shares.

Notify only if

News

Receive news related to Propanc Biopharma, Inc.

Track Activities on PPCB